COVID-19 and the Elderly: Who Cares?

Fischer, Florian; Raiber, Lea; Boscher, Claudia; Winter, Maik H.-J.

doi:10.3389/fpubh.2020.00151

Cited by 40 publications

(31 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…90 WHO reports, 91 95% of COVID-19 deaths occurred in older adults > 60years, more than 50% of all deaths were in people >80years; 8 of 10 deaths had at least one underlying co-morbidity, in particular cardiovascular diseases, hypertension, diabetes, and a range of other chronic conditions. 92,93 Lab confirmed COVID-19 cases presenting with any co-morbidity resulted in poorer clinical outcomes than those without; an increasing number of co-morbidities correlate with poorer clinical outcomes. 94 COVID-19 is highly infectious and can result in fatal comorbidities, particularly acute respiratory distress syndrome (ARDS), 95 involving bilateral pneumonia (75% cases) complicated by ARDS (17%), 86, [96][97][98] a clear indication of ICU admission and mortality in elderly.…”

mentioning

confidence: 86%

<p>The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications</p>

Rahman¹,

Singh²,

Dhingra³

et al. 2020

TCRM

View full text Add to dashboard Cite

COVID-19 pandemic is inducing acute respiratory distress syndrome, multiorgan failure, and eventual death. Respiratory failure is the leading cause of mortality in the elderly population with pre-existing medical conditions. This group is particularly vulnerable to infections due to a declined immune system, comorbidities, geriatric syndrome, and potentially inappropriate polypharmacy. These conditions make the elderly population more susceptible to the harmful effects of medications and the deleterious consequences of infections, including MERS-CoV, SARS-CoV, and SARS-CoV-2. Chronic diseases among elderlies, including respiratory diseases, hypertension, diabetes, and coronary heart diseases, present a significant challenge for healthcare professionals. To comply with the clinical guidelines, the practitioner may prescribe a complex medication regimen that adds up to the burden of pre-existing treatment, potentially inducing adverse drug reactions and leading to harmful side-effects. Consequently, the geriatric population is at increased risk of falls, frailty, and dependence that enhances their susceptibility to morbidity and mortality due to SARS-CoV-2 respiratory syndrome, particularly interstitial pneumonia. The major challenge resides in the detection of infection that may present as atypical manifestations in this age group. Healthy aging can be possible with adequate preventive measures and appropriate medication regimen and follow-up. Adherence to the guidelines and recommendations of WHO, CDC, and other national/regional/international agencies can reduce the risks of SARS-CoV-2 infection. Better training programs are needed to enhance the skill of health care professionals and patient's caregivers. This review explains the public health implications associated with polypharmacy on the geriatric population with pre-existing comorbidities during the COVID-19 pandemic.

show abstract

mentioning

confidence: 86%

<p>The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications</p>

Rahman¹,

Singh²,

Dhingra³

et al. 2020

TCRM

View full text Add to dashboard Cite

show abstract

“…The COVID-19 pandemic has highlighted the need for adequate nursing care for the elderly that is evidence-based and tailored to the needs of this population. A strong public health response and global preparedness to protect the elderly at risk for infectious diseases, including COVID-19, are needed ( 70 ). A commentary contributed by 20 international researchers in the field of aging raised the issues of the lack of preparation for crises, such as COVID-19, in long-term care homes and the initial perception of the public that the virus was a problem of elderly people ( 71 ).…”

Section: Special Attention Welfare and Motivational Activities Durimentioning

confidence: 99%

Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond

Dhama

Patel

Kumar

et al. 2020

Front. Public Health

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic wreaked havoc worldwide, with more than 20 million confirmed cases and nearly 0. 75 million deaths as of 10th August 2020. Various factors determine the severity and symptoms of this infection. Older age and underlying diseases are the challenges being faced in controlling and treating COVID-19. In 2019, 703 million of the global population was older than 65 years of age. The estimated mortality due to COVID-19 in people older than 76 years of age is reportedly 18%. Frequent infections in older people, higher disease severity, and increased mortality are major challenges in the implementation of appropriate preventive measures and future strategies to protect against this disease in geriatric population. Poor health status, weak immune function, lowered organ function, increased probability of multiple underlying diseases, and poor attention to personal health can increase the susceptibility to various diseases in the geriatric population. Concerning inadequate immunity, the decrease expression of receptors and exaggerated pathophysiologic responses can be debilitating. However, future studies will reveal the hidden facets in these aspects in this COVID-19 catastrophe. In this article, we reviewed the main concerns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the geriatric population, including the risk of acquiring severe COVID-19 resulting in mortality, variation in clinical manifestations, and other pandemic-related concerns. We also discussed the need for increasing attention toward the elderly, taking appropriate prevention and control measures, and considering geriatric-related adjustments in vaccine design and development.

show abstract

“…Em consonância com as mudanças ambientais a esse público, a saúde pode ser vista como um reflexo do processo adaptativo na procura da integralidade do indivíduo ANDREWS, 2001). Nessa perspectiva, atualmente a saúde do idoso dentro dos seus aspectos de integralidade, está exposta a grandes desafios, tanto no que se refere à condição biológica, quanto aos aspectos psicológicos, sociais e espirituais, devido à pressão do isolamento e o medo em torno de todo o contexto pandêmico (LEÃO;FERREIRA;FAUSTINO, 2020;FISCHER et al, 2020).…”

Section: Medidas De Enfrentamentounclassified

“…Tendo em vista este cenário, a COVID-19 precisa ser entendida como uma alerta no intuito de garantir uma assistência adequada aos idosos, com base em evidências, nos requisitos do envelhecimento da população, na responsabilidade e no bem-estar social (FISCHER et al, 2020).…”

Section: Introductionunclassified

Medidas de enfrentamento para idosos com covid-19 a luz da teoria adaptativa de callista roy / Coping measures for elderly with covid-19 the light of callista roy adaptive theory

Pereira

Sousa

Bráulio

et al. 2020

BJHR

View full text Add to dashboard Cite

COVID-19 and the Elderly: Who Cares?

Cited by 40 publications

References 7 publications

<p>The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications</p>

<p>The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications</p>

Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond

Medidas de enfrentamento para idosos com covid-19 a luz da teoria adaptativa de callista roy / Coping measures for elderly with covid-19 the light of callista roy adaptive theory

Contact Info

Product

Resources

About